- Home
- SGP vs BCSF Comparison
SGP vs BCSF Comparison
Compare SGP & BCSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SGP | BCSF |
|---|---|---|
| Founded | 2019 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 932.9M | 799.8M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | SGP | BCSF |
|---|---|---|
| Price | $24.56 | $13.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $45.00 | $14.00 |
| AVG Volume (30 Days) | 78.4K | ★ 429.1K |
| Earning Date | 05-15-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 14.40% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.53 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.86 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $20.15 | $11.82 |
| 52 Week High | $30.56 | $16.00 |
Technical Indicators
Market Signals| Indicator | SGP | BCSF |
|---|---|---|
| Relative Strength Index (RSI) | 50.86 | 69.07 |
| Support Level | $20.60 | $13.41 |
| Resistance Level | $28.17 | $13.83 |
| Average True Range (ATR) | 1.91 | 0.28 |
| MACD | 0.36 | 0.15 |
| Stochastic Oscillator | 62.33 | 95.60 |
Price Performance
Historical ComparisonAbout SGP SpyGlass Pharma Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing in middle-market companies. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan, and others.